Literature DB >> 25862775

American society of Nephrology Quiz and Questionnaire 2014: transplantation.

Michelle A Josephson1, Mark A Perazella2, Michael J Choi3.   

Abstract

The Nephrology Quiz and Questionnaire remains an extremely popular session for attendees of the Annual Kidney Week Meeting of the American Society of Nephrology. Once again, the conference hall was overflowing with audience members and eager quiz participants. Topics covered by the expert discussants included electrolyte and acid-base disorders, glomerular disease, ESRD/dialysis, and transplantation. Complex cases representing each of these categories along with single best answer questions were prepared and submitted by the panel of experts. Before the meeting, program directors of United States nephrology training programs and nephrology fellows answered the questions through an internet-based questionnaire. During the live session, members of the audience tested their knowledge and judgment on a series of case-oriented questions prepared and discussed by experts. They compared their answers in real time using audience response devices with the answers of the nephrology fellows and training program directors. The correct and incorrect answers were then discussed after the audience responses and the results of the questionnaire were displayed. As always, the audience, lecturers, and moderators enjoyed this educational session. This article recapitulates the session and reproduces its educational value for the readers of CJASN. Enjoy the clinical cases and expert discussions.
Copyright © 2015 by the American Society of Nephrology.

Entities:  

Keywords:  anemia; kidney transplantation; vascular

Mesh:

Substances:

Year:  2015        PMID: 25862775      PMCID: PMC4422252          DOI: 10.2215/CJN.12221214

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  28 in total

Review 1.  A cluster of parvovirus B19 infections in renal transplant recipients: a prospective case series and review of the literature.

Authors:  O Egbuna; M S Zand; A Arbini; M Menegus; J Taylor
Journal:  Am J Transplant       Date:  2006-01       Impact factor: 8.086

2.  The prevalence of antibody to human parvovirus B19 in England and Wales.

Authors:  B J Cohen; M M Buckley
Journal:  J Med Microbiol       Date:  1988-02       Impact factor: 2.472

3.  Parvovirus infection after renal transplant.

Authors:  G Neild; M Anderson; S Hawes; B T Colvin
Journal:  Lancet       Date:  1986-11-22       Impact factor: 79.321

4.  Erythrocyte P antigen: cellular receptor for B19 parvovirus.

Authors:  K E Brown; S M Anderson; N S Young
Journal:  Science       Date:  1993-10-01       Impact factor: 47.728

5.  Antiviral effect of cidofovir on parvovirus B19 replication.

Authors:  Francesca Bonvicini; Gloria Bua; Elisabetta Manaresi; Giorgio Gallinella
Journal:  Antiviral Res       Date:  2014-11-13       Impact factor: 5.970

6.  Parvovirus B19 infection in an isolated pancreas transplant recipient.

Authors:  A A Onitilo; G R Shaw
Journal:  Transplant Proc       Date:  2005-12       Impact factor: 1.066

7.  Long-term remission of recurrent parvovirus-B associated anemia in a renal transplant recipient induced by treatment with immunoglobulin and positive seroconversion.

Authors:  J Kumar; M J Shaver; S Abul-Ezz
Journal:  Transpl Infect Dis       Date:  2005-03       Impact factor: 2.228

8.  A reversible posterior leukoencephalopathy syndrome.

Authors:  J Hinchey; C Chaves; B Appignani; J Breen; L Pao; A Wang; M S Pessin; C Lamy; J L Mas; L R Caplan
Journal:  N Engl J Med       Date:  1996-02-22       Impact factor: 91.245

9.  Parvovirus-like particles in human sera.

Authors:  Y E Cossart; A M Field; B Cant; D Widdows
Journal:  Lancet       Date:  1975-01-11       Impact factor: 79.321

10.  DC-SIGN is a receptor for human herpesvirus 8 on dendritic cells and macrophages.

Authors:  Giovanna Rappocciolo; Frank J Jenkins; Heather R Hensler; Paolo Piazza; Mariel Jais; Luann Borowski; Simon C Watkins; Charles R Rinaldo
Journal:  J Immunol       Date:  2006-02-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.